Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

<p dir="ltr">Cancer is a complex disease displaying a variety of cell states and phenotypes. This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. This re...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Gh Rasool Bhat (13038132) (author)
مؤلفون آخرون: Itty Sethi (6701723) (author), Hana Q. Sadida (15376385) (author), Bilal Rah (137862) (author), Rashid Mir (2616949) (author), Naseh Algehainy (21633089) (author), Ibrahim Altedlawi Albalawi (21734558) (author), Tariq Masoodi (8117702) (author), Gowtham Kumar Subbaraj (17807615) (author), Farrukh Jamal (8605026) (author), Mayank Singh (793077) (author), Rakesh Kumar (8432) (author), Muzafar A. Macha (11605200) (author), Shahab Uddin (154400) (author), Ammira S. Al-Shabeeb Akil (15376391) (author), Mohammad Haris (564809) (author), Ajaz A. Bhat (12984701) (author)
منشور في: 2024
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513544642363392
author Gh Rasool Bhat (13038132)
author2 Itty Sethi (6701723)
Hana Q. Sadida (15376385)
Bilal Rah (137862)
Rashid Mir (2616949)
Naseh Algehainy (21633089)
Ibrahim Altedlawi Albalawi (21734558)
Tariq Masoodi (8117702)
Gowtham Kumar Subbaraj (17807615)
Farrukh Jamal (8605026)
Mayank Singh (793077)
Rakesh Kumar (8432)
Muzafar A. Macha (11605200)
Shahab Uddin (154400)
Ammira S. Al-Shabeeb Akil (15376391)
Mohammad Haris (564809)
Ajaz A. Bhat (12984701)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Gh Rasool Bhat (13038132)
Itty Sethi (6701723)
Hana Q. Sadida (15376385)
Bilal Rah (137862)
Rashid Mir (2616949)
Naseh Algehainy (21633089)
Ibrahim Altedlawi Albalawi (21734558)
Tariq Masoodi (8117702)
Gowtham Kumar Subbaraj (17807615)
Farrukh Jamal (8605026)
Mayank Singh (793077)
Rakesh Kumar (8432)
Muzafar A. Macha (11605200)
Shahab Uddin (154400)
Ammira S. Al-Shabeeb Akil (15376391)
Mohammad Haris (564809)
Ajaz A. Bhat (12984701)
author_role author
dc.creator.none.fl_str_mv Gh Rasool Bhat (13038132)
Itty Sethi (6701723)
Hana Q. Sadida (15376385)
Bilal Rah (137862)
Rashid Mir (2616949)
Naseh Algehainy (21633089)
Ibrahim Altedlawi Albalawi (21734558)
Tariq Masoodi (8117702)
Gowtham Kumar Subbaraj (17807615)
Farrukh Jamal (8605026)
Mayank Singh (793077)
Rakesh Kumar (8432)
Muzafar A. Macha (11605200)
Shahab Uddin (154400)
Ammira S. Al-Shabeeb Akil (15376391)
Mohammad Haris (564809)
Ajaz A. Bhat (12984701)
dc.date.none.fl_str_mv 2024-02-08T03:00:00Z
dc.identifier.none.fl_str_mv 10.1007/s10555-024-10172-z
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Cancer_cell_plasticity_from_cellular_molecular_and_genetic_mechanisms_to_tumor_heterogeneity_and_drug_resistance/29590346
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Cancer cell plasticity
Cancer stem cells
Epithelial-mesenchymal transition
Tumor heterogeneity
Drug resistance
Targeted therapies
dc.title.none.fl_str_mv Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Cancer is a complex disease displaying a variety of cell states and phenotypes. This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. This review explores the intricate landscape of cancer cell plasticity, offering a deep dive into the cellular, molecular, and genetic mechanisms that underlie this phenomenon. Cancer cell plasticity is intertwined with processes such as epithelial-mesenchymal transition and the acquisition of stem cell–like features. These processes are pivotal in the development and progression of tumors, contributing to the multifaceted nature of cancer and the challenges associated with its treatment. Despite significant advancements in targeted therapies, cancer cell adaptability and subsequent therapy-induced resistance remain persistent obstacles in achieving consistent, successful cancer treatment outcomes. Our review delves into the array of mechanisms cancer cells exploit to maintain plasticity, including epigenetic modifications, alterations in signaling pathways, and environmental interactions. We discuss strategies to counteract cancer cell plasticity, such as targeting specific cellular pathways and employing combination therapies. These strategies promise to enhance the efficacy of cancer treatments and mitigate therapy resistance. In conclusion, this review offers a holistic, detailed exploration of cancer cell plasticity, aiming to bolster the understanding and approach toward tackling the challenges posed by tumor heterogeneity and drug resistance. As articulated in this review, the delineation of cellular, molecular, and genetic mechanisms underlying tumor heterogeneity and drug resistance seeks to contribute substantially to the progress in cancer therapeutics and the advancement of precision medicine, ultimately enhancing the prospects for effective cancer treatment and patient outcomes.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancer and Metastasis Reviews<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s10555-024-10172-z" target="_blank">https://dx.doi.org/10.1007/s10555-024-10172-z</a></p>
eu_rights_str_mv openAccess
id Manara2_485791cf656dd6e0acdbe979b078e5d5
identifier_str_mv 10.1007/s10555-024-10172-z
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29590346
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistanceGh Rasool Bhat (13038132)Itty Sethi (6701723)Hana Q. Sadida (15376385)Bilal Rah (137862)Rashid Mir (2616949)Naseh Algehainy (21633089)Ibrahim Altedlawi Albalawi (21734558)Tariq Masoodi (8117702)Gowtham Kumar Subbaraj (17807615)Farrukh Jamal (8605026)Mayank Singh (793077)Rakesh Kumar (8432)Muzafar A. Macha (11605200)Shahab Uddin (154400)Ammira S. Al-Shabeeb Akil (15376391)Mohammad Haris (564809)Ajaz A. Bhat (12984701)Biomedical and clinical sciencesOncology and carcinogenesisPharmacology and pharmaceutical sciencesCancer cell plasticityCancer stem cellsEpithelial-mesenchymal transitionTumor heterogeneityDrug resistanceTargeted therapies<p dir="ltr">Cancer is a complex disease displaying a variety of cell states and phenotypes. This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. This review explores the intricate landscape of cancer cell plasticity, offering a deep dive into the cellular, molecular, and genetic mechanisms that underlie this phenomenon. Cancer cell plasticity is intertwined with processes such as epithelial-mesenchymal transition and the acquisition of stem cell–like features. These processes are pivotal in the development and progression of tumors, contributing to the multifaceted nature of cancer and the challenges associated with its treatment. Despite significant advancements in targeted therapies, cancer cell adaptability and subsequent therapy-induced resistance remain persistent obstacles in achieving consistent, successful cancer treatment outcomes. Our review delves into the array of mechanisms cancer cells exploit to maintain plasticity, including epigenetic modifications, alterations in signaling pathways, and environmental interactions. We discuss strategies to counteract cancer cell plasticity, such as targeting specific cellular pathways and employing combination therapies. These strategies promise to enhance the efficacy of cancer treatments and mitigate therapy resistance. In conclusion, this review offers a holistic, detailed exploration of cancer cell plasticity, aiming to bolster the understanding and approach toward tackling the challenges posed by tumor heterogeneity and drug resistance. As articulated in this review, the delineation of cellular, molecular, and genetic mechanisms underlying tumor heterogeneity and drug resistance seeks to contribute substantially to the progress in cancer therapeutics and the advancement of precision medicine, ultimately enhancing the prospects for effective cancer treatment and patient outcomes.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancer and Metastasis Reviews<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s10555-024-10172-z" target="_blank">https://dx.doi.org/10.1007/s10555-024-10172-z</a></p>2024-02-08T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s10555-024-10172-zhttps://figshare.com/articles/journal_contribution/Cancer_cell_plasticity_from_cellular_molecular_and_genetic_mechanisms_to_tumor_heterogeneity_and_drug_resistance/29590346CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/295903462024-02-08T03:00:00Z
spellingShingle Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh Rasool Bhat (13038132)
Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Cancer cell plasticity
Cancer stem cells
Epithelial-mesenchymal transition
Tumor heterogeneity
Drug resistance
Targeted therapies
status_str publishedVersion
title Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
title_full Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
title_fullStr Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
title_full_unstemmed Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
title_short Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
title_sort Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
topic Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Cancer cell plasticity
Cancer stem cells
Epithelial-mesenchymal transition
Tumor heterogeneity
Drug resistance
Targeted therapies